Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients

By Ko Kyung   Shin In   You Ji   Jung So-Youn   Ro Jungsil   Lee Eun  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 559-567

Springer Publishing Company

Access to resources Recommend Favorite

Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy

By Kim Hee  

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 777-788

Springer Publishing Company

Access to resources Recommend Favorite

Tamoxifen Added to Adjuvant Chemotherapy in Premenopausal Women with Early Breast Cancer: is it Standard Practice or Still a Subject for Study?

By Bramwell V.H.C.   Pritchard K.I.  

European Journal of Cancer, Vol. 35, Iss. 12, 1999-11 ,pp. : 1625-1627

Elsevier

Access to resources Recommend Favorite

Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrinedependent breast cancer: A report of two cases

By          

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1279-1282

Spandidos Publications

Access to resources Recommend Favorite

Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide

By Johansson Harriet   Bonanni Bernardo   Gandini Sara   Guerrieri-Gonzaga Aliana   Cazzaniga Massimiliano   Serrano Davide   Macis Debora   Puccio Antonella   Sandri Maria   Gulisano Marcella   Formelli Franca   DeCensi Andrea  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 569-578

Springer Publishing Company

Access to resources Recommend Favorite